Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]

Draft guidance: 1

Draft consultation document (downloadable version) (PDF 284 KB)

Draft consultation document (online commenting)

Committee papers (PDF 5.47 MB)

Public committee slides (PDF 804 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 263 KB)

Final scope (PDF 202 KB)

Final stakeholder list (PDF 177 KB)

Draft matrix post referral (PDF 165 KB)